Identification of a second 14-3-3-binding site at serine 52. (A) Schematic depiction of murine TTP showing the wild-type (wt) sequence of 14-3-3-binding sites surrounding serine 52 and 178. Mutations S52A, S178A, V54P and S180P are indicated. NES: nuclear export signal; ZFD: zinc-finger domain; 14-3-3bs: 14-3-3-binding site. (B) Co-precipitation of TTP mutants and 14-3-3. COS7 cells were transfected with vector control (lane 1) or TTP-myc (lanes 2 and 3), TTP-S52A-myc (lanes 4 and 5), TTP-S178A-myc (lanes 6 and 7), TTP-AA-myc (S52A/S178A; lanes 8 and 9), TTP-V54P-myc (lane 10), TTP-S180P-myc (lane 11) and TTP-PP-myc (V54P/S180P; lane 12). Cells were cultured in media alone (lanes 1, 2, 4, 6, 8 and 10–12) or media containing arsenite (ARS, 0.5 mM, 60 min; lane 3, 5, 7 and 9), and processed as described for Figure 5A. (C) Quantitative immunofluorescence analysis showing the percentage of transfected cells in which mutant TTP accumulates in SGs (average values±s.e.m. of n⩾3 independent experiments). COS7 cells were transfected with TTP-myc, TTP-S52A-myc, TTP-S178A-myc, TTP-AA-myc, TTP-V54P-myc, TTP-S180P-myc and TTP-PP-myc, and processed as described for Figure 3B. (D) Representative immunofluorescence micrographs of COS7 cells transfected with TTP-AA-myc and treated with arsenite (ARS, 0.5 mM, 60 min) or (E) COS7 cells transfected with TTP-PP-myc and not treated with arsenite. Left panels show the myc-tagged TTP mutants (red), center panels show TIA-1 as a marker of SGs (green, arrows) and right panels show merged views. Size bar is 10 μm.